Opendata, web and dolomites
H2020 projects about "antigen"
The page lists 138 projects related to the topic "antigen".
| # | |||
|---|---|---|---|
| 1 | PROCROP | Professional cross-priming for ovary and prostate cancer | 2015 |
| 2 | PredicTOOL | Nanomethods to understand what makes an endogenous protein immunogenic | 2015 |
| 3 | DNAendProtection | DNA end protection in Immunity and Cancer | 2015 |
| 4 | Crosstag | Unravelling cross-presentation pathways using a chemical biology approach | 2015 |
| 5 | BLOODCELLSCROSSTALK | The Crosstalk Between Red And White Blood Cells: The Case Of Fish | 2015 |
| 6 | Rethyming | Rebuilding the human thymus to create a tolerising system for allogeneic tissue and organ transplantation | 2015 |
| 7 | SOS | Sorting of Self | 2015 |
| 8 | PRISAR | Preclinical Intra-Operative Image-Guided Surgery and Post-Operative Radiotherapy of Tumours | 2015 |
| 9 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
| 10 | CARiPSCTcells | Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application | 2015 |
| 11 | LABVaccFish | USE OF LACTIC ACID BACTERIA AS DELIVERY VEHICLE FOR ORAL VACCINATION OF FISH | 2016 |
| 12 | KCs and Gut Antigens | Elucidating the role of liver resident Kupffer cells in the regulation of the immune responses to intestinal antigens | 2015 |
| 13 | NESIAC | Nanobody-enabled Structural Investigation of a G Protein-Coupled Receptor-Arrestin Complex | 2015 |
| 14 | LYMPHOSIGN | Integrated study of the role of B-cell receptor signaling in the development of Follicular Lymphoma | 2015 |
| 15 | PCSP | Odour-GPCRs based technology for detection and stratification of cancer: Prostate Cancer Smell Print as first vertical market | 2015 |
| 16 | SVNanoVax | Structural Vaccinology in the design of bionanoparticles with multi-copy antigen display for vaccines with enhanced efficacy | 2015 |
| 17 | PREVENT | Prostate cancer extracellular vesicles as biomarkers for nanomedicine treatment | 2015 |
| 18 | NEWCARBOVAX | New generation of carbohydrate-based vaccines via rational understanding of their immunological mechanism | 2017 |
| 19 | ProCanEx | Prostate cancer diagnostic assay based on protein kinase activity profiling in exosomes | 2015 |
| 20 | PERSYST | Generation and maintenance of long-lived memory T cells in humans | 2015 |
| 21 | TIPPDECRA | Tolerogenic immunotherapy with peptide-pulsed dendritic cells in rheumatoid arthritis | 2016 |
| 22 | BCELLMECHANICS | Regulation of antibody responses by B cell mechanical activity | 2015 |
| 23 | GLYCOVAX | A training network for the rational design of the next generation of well-defined glycoconjugate vaccines | 2015 |
| 24 | M-Imm | Novel etiology of autoimmune disorders: the role of acquired somatic mutations in lymphoid cells | 2015 |
| 25 | SYNECT | Immunological synapse derived ectosomes in T cell effector function | 2015 |
| 26 | CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies | 2016 |
| 27 | RELENT | RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities | 2015 |
| 28 | SAFEIMMUNOSUPPRESS | Development of immunosuppressive treatments with better safety | 2016 |
| 29 | VADEMA | Doctoral Industrial School for Vaccine Design through Structural Mass Spectrometry | 2016 |
| 30 | MCNTMTDC | Metabolic control on NF-κB activity during dendritic cells-mediated immune tolerance to tumours | 2017 |
| 31 | DynOMIS | Dynamic Origins of MHC class I Selector function | 2016 |
| 32 | LIPID IMMUNITY | Regulation of lipid-mediated immunity in the intestine | 2016 |
| 33 | HONEYDIAB-8 | Characterization of islet-specific CD8 T cells in the honeymoon of type 1 diabetes | 2016 |
| 34 | Exosomes | Regulated secretion and role of urinary nanovesicles | 2017 |
| 35 | NANOBreg | A new therapeutic platform based on nanotechnology to promote T- and B-regulatory networks | 2016 |
| 36 | nextDART | Next-generation Detection of Antigen Responsive T-cells | 2016 |
| 37 | FIBROCAN | Defining the immunological interplay between fibroblastic reticular cells and anti-tumour T cells | 2016 |
| 38 | PIGYVAX | Making a yeast-based candidate vaccine against Porcine Epidemic Diarrhea Virus (PEDV) | 2016 |
| 39 | HepatoMetaboPath | Cellular and molecular mechanisms of metabolic immune activation triggering non-alcoholic steatohepatitis (NASH) and HCC | 2016 |
| 40 | ERCOPE | The ER located master regulation of endosomal positioning and further movements | 2016 |
| 41 | Autonomous CLL-BCRs | Role of autonomous B cell receptor signalling and external antigen in the pathogenesis of chronic lymphocytic leukaemia (CLL) | 2016 |
| 42 | ILC_REACTIVITY | Biological Determinants of ILC Reactivity for Immune Responses in Health and Disease | 2016 |
| 43 | ADC | Next-Generation Antibody-Drug Conjugates for safer and more effective cancer therapies | 2016 |
| 44 | SweetAim | Selective glycoimmuno-targeting for cancer therapy | 2016 |
| 45 | MAGNAMED | Novel magnetic nanostructures for medical applications | 2017 |
| 46 | ZIKAVAX | Fast track development of a Zika vaccine based on measles vector | 2016 |
| 47 | OptiMalVax | Optimizing a deployable high efficacy malaria vaccine | 2017 |
| 48 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 49 | EVOLVE | Extracellular Vesicle-Internalizing Receptors (EVIRs) for Cancer ImmunoGeneTherapy | 2017 |
| 50 | STRUGGLE | Statistical physics of immune-viral co-evolution | 2017 |
| 51 | VIVAVE | Viral Vaccine Vectors in Personalized Medicine | 2017 |
| 52 | 3D_Tryps | The role of three-dimensional genome architecture in antigenic variation | 2017 |
| 53 | TracVac | Developing a Chlamydia Trachomatis vaccine | 2017 |
| 54 | MIRA | Characterizing Microbe-specific Immune Responses in the pathogenesis of Autoimmunity | 2017 |
| 55 | ILTIS | Innate-Like T-Cells In Sepsis (ILTIS): Implications for Early Diagnosis and Rescue of Immune Suppression. | 2017 |
| 56 | SupaSteD | Suppresion of adaptive immunity by the Salmonella effector SteD | 2017 |
| 57 | GLIOMA | Targeting Glioblastoma using Combinatorial Therapeutic Nanovaccine | 2017 |
| 58 | DevoSignGammaDelta | Tracking γδ T cell development and TCRγδ proximal signalling | 2018 |
| 59 | CD4CRISPR | A quorum sensing mechanism regulating CD4 T cell proliferation | 2017 |
| 60 | IMMUNO-RQC | Role of Listerin ubiquitin ligase in MHC-I antigen presentation | 2017 |
| 61 | PolyVac | Polysaccharide-based membrane for sublingual vaccination | 2017 |
| 62 | THAT IS HUNT | Triggering Haematological Adoptive T-cell Immunotherapy Strategies by HUnting Novel T-cellreceptors | 2018 |
| 63 | CAR ART | Chimeric Antigen Receptor to generate Alloantigen-specific Regulatory T cells and promote allograft tolerance | 2017 |
| 64 | TANTUMorNEUVACCINE | Neutrophil subtypes: distinct cellular targets for therapeutic intervention | 2017 |
| 65 | ThymusTolerance | Delineation of molecular mechanisms underlying the establishment and breakdown of immunological tolerance in the thymus | 2017 |
| 66 | IMMOVA | Novel Immunotherapeutic Vaccine for the treatment of Alzheimer’s disease | 2017 |
| 67 | INTACt | ImmuNogenomics TArgeting Cancer | 2017 |
| 68 | STEPUP | Synthetic DCs for a T cEll ProdUction Platform | 2017 |
| 69 | STOPCa | The cryptic path of tumor-microenvironment interactions in prostate cancer | 2017 |
| 70 | TOLERANCE FOOTPRINT | Clonal Deletion versus Clonal Diversion: Footprints of Self-Tolerance in the T CellRepertoire | 2017 |
| 71 | SELFOR | How our adaptive immune system separates “self” from “foreign” – a physicochemical study of binding in cell contacts | 2018 |
| 72 | VDJtargeting | Engineering T cells and B cells for Immunotherapy using V(D)J recombination | 2017 |
| 73 | COSMIC | COmbatting disorders of adaptive immunity with Systems MedICine | 2018 |
| 74 | RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION | 2018 |
| 75 | OMVCRC | Engineered bacterial Outer Membrane Vesicles (OMVs) for colorectal cancer immunotherapy | 2018 |
| 76 | DC_Nutrient | Investigating nutrients as key determinants of DC-induced CD8 T cell responses | 2018 |
| 77 | TC-Evo | Molecular and functional evolution of human CD8+ T cell repertoires | 2018 |
| 78 | InTheMLLrBALL | Innovative Therapeutic Strategies for Mixed Lineage Leukemia-rearranged B-cell Acute Lymphoblastic Leukemia | 2018 |
| 79 | Striking streaks | Invariant Natural Killer T-cells in atherogenesis | 2018 |
| 80 | MAGIC | Magnification of Asthma by human memory Group 2 Innate lymphoid Cells | 2018 |
| 81 | FUCTURE | Fucosylated Clusterin: a novel mechanism of tumor escape from immune response | 2018 |
| 82 | MATURE-NK | MAnufacturing of TUmour-REactive Natural Killer cells | 2018 |
| 83 | BASILIC | Decoding at systems-level the crosstalk between the T cell antigen receptor, the CD28 costimulator and the PD-1 coinhibitor under physiological and pathological conditions. | 2018 |
| 84 | EditMHC | How MHC-I editing complexes shape the hierarchical immune response | 2019 |
| 85 | SUMMIT | Stepping Up mRNA Mutanome Immunotherapy | 2018 |
| 86 | CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease | 2018 |
| 87 | vAMRes | Vaccines as a remedy for antimicrobial resistant bacterial infections | 2018 |
| 88 | IT4B-ALL | Therapeutic immunotherapy targeting NG2 and CD22 antigens for MLL-rearranged and MLL-germline B-cell Acute Lymphoblastic Leukemia | 2019 |
| 89 | SOMIT | Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease | 2018 |
| 90 | ActinSensor | Identification and characterization of a novel damage sensor for cytoskeletal proteins in Drosophila | 2019 |
| 91 | COR1-TCELL | Analysis of the role for coronin 1-dependent cell density signalling in T-cell homeostasis | 2019 |
| 92 | LIPOBITS | Liposome-based Biomimetic Treatment for auto-immune diabetes (T1D) | 2018 |
| 93 | GLIOVACC | Augmenting and broadening T-cell responses to glioblastoma - therapeutic vaccine platform based on HCMV expressing NKG2D ligands | 2018 |
| 94 | RESHAPE | Reshaping undesired Inflammation in challenged Tissue Homeostasis by Next-Generation regulatory T cell (Treg) Approaches – from Advanced Technology Developments to First-in-Human Trials | 2019 |
| 95 | Nevada | Diagnostics device for rapid testing of prostate cancer at Point-of-care | 2018 |
| 96 | AutoCAb | Automated computational design of site-targeted repertoires of camelid antibodies | 2019 |
| 97 | POLYMMUNE | Off-the-Shelf Polypeptide-based Immunotherapy for Advanced Melanoma Treatment | 2019 |
| 98 | FuncMAB | High-throughput single-cell phenotypic analysis of functional antibody repertoires | 2019 |
| 99 | TCRabX | Structural basis for the therapeutic efficiency of optimal-affinity T cell receptors | 2019 |
| 100 | DCRIDDLE | A novel physiological role for IRE1 and RIDD..., maintaining the balance between tolerance and immunity? | 2019 |
| 101 | GlyCan | Innovative Glycan-based analysis for Cancer diagnostics | 2019 |
| 102 | STEP 2 | Spatiotemporal regulation of T-cell Priming | 2019 |
| 103 | Lakhesys | Lakhesys: building the machine to make the medicines of tomorrow | 2019 |
| 104 | iDysChart | Charting key molecules and mechanisms of human immune Dysregulation | 2019 |
| 105 | SYNKIT | Synthetic Natural Killer Cells for Immunotherapy | 2020 |
| 106 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
| 107 | BispecificsThatClick | Combinatorial Antibody Synthesis for the Discovery of New Anti-Tumour Immunomodulators | 2019 |
| 108 | Exh-Res-CART | Exhaustion-resistant CAR-T cells for the treatment of solid tumours | 2019 |
| 109 | MGLycan | Targeting hMGL-GalNAc interactions to reverse immune suppression in cancer | 2019 |
| 110 | LUNG-BIM | Induction of B cell immunity in the lung mucosa | 2019 |
| 111 | INFORM | Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs | 2020 |
| 112 | CRUZIVAX | Vaccine for prevention and treatment of Trypanosoma cruzi infection | 2019 |
| 113 | SHIGETECVAX | Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea | 2019 |
| 114 | ImmUne | Towards identification of the unifying principles of vertebrate adaptive immunity | 2019 |
| 115 | B-different | The RNA-Binding Protein ZFP36L1 regulates the terminal differentiation of B lymphocytes | 2020 |
| 116 | Metabinnate | Metabolic crosstalk in the regulation of inflammation | 2019 |
| 117 | CAN-IT-BARRIERS | Disruption of systemic and microenvironmental barriers to immunotherapy of antigenic tumors | 2020 |
| 118 | PI3K-in-tolerance | PI3K delta role in dendritic cell antigen processing and presentation to control gut tolerance | 2019 |
| 119 | T-NHL SUPRESSORS | Tumor suppressor pathways counteracting oncogenic immune receptor signaling in T-Cell Lymphoma | 2019 |
| 120 | VACCIBIOME | Cancer Vaccines and Gut Microbiome: a rational approach to optimize cancer immunotherapy | 2019 |
| 121 | Malaria POC | Ultrasensitive detection of transmissible malaria | 2019 |
| 122 | BactiVax | anti-Bacterial Innovative Vaccine Training Network. | 2019 |
| 123 | ANIMATE | Adaptive Immunity in Human Atherosclerosis: Understanding its Cellular Basis to Define Novel Immunomodulatory Therapies | 2020 |
| 124 | B-DOMINANCE | B Cell Immunodominance in Antiviral Immunity | 2019 |
| 125 | VIVA | Vaccine development against variable pathogens | 2020 |
| 126 | SYNVIVO | Revealing dendritic cell-CD4+ T cell communication by using synthetic biology in vivo | 2020 |
| 127 | TrojanDC | TrojanDC | 2019 |
| 128 | Synthetic T-rEX | A synthetic biology approach for T cell exhaustion | 2020 |
| 129 | PANDORA | Pandemics Outbreaks Rationalized: towards a universal therapy to eliminate intracellular pathogens and drug resistance | 2020 |
| 130 | GUT-SEQ | Single-cell analysis of intestinal lymphocytes reveals targets for treatment of inflammatory bowel disease | 2020 |
| 131 | POST-IT | Pathogen Oriented SNARE Trafficking for Immune Tailoring | 2020 |
| 132 | TrojanDC | Harnessing dendritic cell reprogramming for cancer immunotherapy | 2020 |
| 133 | INCENTIVE | Indo-European Consortium for Next Generation Influenza Vaccine Innovation | 2020 |
| 134 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 135 | QS21-Mech | Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) | 2020 |
| 136 | BraINstorm | Engineered nanocarriers for simultaneous anticancer immune response and “switching” of tumor-associated macrophages for intranasal glioblastoma treatment | 2020 |
| 137 | PATHOCODE | Molecular pathology of anti-viral T cell responses in the central nervous system | 2020 |
| 138 | SIGNAL | Sensing Neuro-immune Activation in the Lung microenvironment | 2020 |